Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medaphor Group PLC announces admission and first day of dealings


Wednesday, 27 Aug 2014 02:00am EDT 

Medaphor Group PLC:Announces admission to trading on AIM.Says dealings in Co's ordinary shares will trade under TIDM MED.Placing has raised about 4.7 mln Pound, before expenses, through placing of 9,366,300 ordinary shares.Number of ordinary shares in issue immediately after admission will be 20,124,300, giving company market capitalisation of 10.1 mln Pound at placing price of 0.50 Pound per ordinary share.Net proceeds received from will be principally used to fund expansion of Company's sales network globally and to fund development of new applications for ScanTrainer technology platform within complementary medical markets.Says Cenkos Securities is acting as Nominated Adviser and Broker to the Company. 

Company Quote

49.5
0.0 +0.00%
4 Feb 2016